Bioinformatics Market (Product: Bioinformatics Platforms, Bioinformatics Services, Knowledge Management Tools, Biocontent; By Application: Genomics, Molecular Phylogenetics, Metabolomics, Proteomics, Transcriptions, Chemoinformatics and Drug Designing, Others; By Sector: Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, Other Sectors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022 – 2030


The global bioinformatics market size is projected to surpass around US$ 45.6 billion by 2030 from US$ 13.2 billion in 2021, progressing at a CAGR of 16.3% during the forecast period 2022 to 2030.

Bioinformatics Market Size, 2021 to 2030

Growth Factors

The combination of biology and information technology is known as bioinformatics. Various tools and software are used in bioinformatics such as data management, data creation, data warehousing, and data mining. The market for bioinformatics is growing due to the expansion of pharmaceutical sector. The pharmaceutical industry in Europe was valued at $139,287 million in 2000 as per the European Federation of Pharmaceutical Industries and Associations’ statistics of 2019, and it climbed to $284,028 million in 2018. In addition, due to various benefits provided by bioinformatics is driving the market growth.

The COVID-19 pandemic had a positive impact on the growth of global bioinformatics market. The early detection of virus using bioinformatics opened new growth opportunities for global bioinformatics market. The bioinformatics were also used for the development of drugs and vaccines. Moreover, various strategic alliances were formed during COVID-19 pandemic in global bioinformatics market. The UK government, for example, announced the COVID-19 Genomics UK Consortium in March 2020 with a $21 million investment to sequence the genomes of SARS-CoV-2, the virus involved during COVID-19 epidemic, using genome sequencing. The Public Health Agencies and the NHS and a number of research institutes make up the COVID-19 Genomics UK Consortium. 

Another factor boosting the growth of global bioinformatics market is growing investments in biology and information technology sectors. Moreover, government all around the world is taking constant efforts for the development of global bioinformatics market. The bioinformatics tools and software are mostly used for cutting down the extra cost and expenses related to drug development process. This factor is supporting the growth of global bioinformatics market.

On the other hand, the growth of global bioinformatics market is being restricted by lack of skilled professionals and lack of resources in developing economy. Moreover, the use of alternative tools will also hinder the expansion of global bioinformatics market.

To offer latest and new products and maintain their market positions around the globe, major market players in the global bioinformatics market are using various methods such as collaborations and acquisitions with other organizations. The key market players are collaborating to develop a next-generation sequencing based assay that assesses cancer relevant genetic changes using RNA and DNA produced from a patient’s tumor in a single process.

Furthermore, the release of technologically developed bioinformatics tools and software such as AUTODOCK, BALL, and RasMol as well as increased market utilization of these tools for accurate and precise analysis of biomarkers discovery programs that aid in contamination sensing during the early stages of the drug development process are expected to propel the growth of global bioinformatics market.

Report Scope of the Bioinformatics Market

Report Coverage Details
Market Size by 2030 USD 45.6 Billion
Growth Rate from 2022 to 2030

CAGR of 16.3%

Largest Market North America
Fastest Growing Market Europe
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Application, Sector, Geography
Companies Mentioned Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies Inc., Illumina Inc., Waters Corporation, NeoGenomics Laboratories, Perkin Elmer Inc., Fios Genomics, and Source BioScience

Product Insights

The bioinformatics services segment dominated the bioinformatics market in 2021. The factors such as growing initiatives regarding research and development as well as surge in demand for novel drugs are boosting the growth of bioinformatics services segment. Furthermore, the technological advancements are resulting into the growing demand for bioinformatics services in the global market. 

Bioinformatics Market Share, By Product, 2021 (%)

The bioinformatics platforms segment is fastest growing segment of the bioinformatics market in 2020. The growing usage of various tools for database management is driving the growth of bioinformatics platforms. The high utilization of next generation sequencing is also contributing to the growth of bioinformatics platforms. In addition, the growing demand for exome and genome technologies is driving the segment growth.

Application Insights

The genomic segment dominated the bioinformatics market in 2021. The demand for bioinformatics is growing in genomics due to adoption of new and innovative technologies. The bioinformatics in pharmacogenomics are used for handling and managing large amount of data and information in database. The sequencing technology is widely used in drug development process. This is directly impacting the growth of genomic segment over the forecast period.

The proteomics segment is fastest growing segment of the bioinformatics market in 2020. The growth of proteomics segment is attributed to the rising research and development initiatives and high investments for the development of technologies. These technologies help to analyze and manage data on a large scale. Moreover, algorithms are also used for managing and monitoring data in database. All these factors are driving the growth of the proteomics segment.

Region Insights

North America dominated the bioinformatics market in 2021. The bioinformatics market in North America is growing due to the favorable government regulations in favor of market players. In addition, the growth of North America bioinformatics market is also attributed to the existence of major market players. The government of the U.S. is investing towards the development of bioinformatics market. Furthermore, expanding research and development activities are paving way for the expansion of bioinformatics market in the region.

Bioinformatics Market Share, By Region, 2021 (%)

Europe, on the other hand, is expected to develop at the fastest rate during the forecast period. The UK, Italy, and France dominate the bioinformatics market in Europe region. The growing investments in healthcare sector are driving the growth of Europe bioinformatics market. Moreover, the adoption of innovative technologies such as artificial intelligence and internet of things are contributing towards the growth of bioinformatics market in Europe. The market players operating in Europe bioinformatics market are adopting strategies such as partnership and acquisition.

Key Developments 

  • Brunei’s Ministry of Health and BGI extended their collaboration in January 2021 to include women’s healthcare, individualized drug counselling, early cancer detection, and the discovery of unknown diseases utilizing BGI’s innovative sequencing technology. 
  • Eurofins Scientific delivered enhanced and profitable SARS-CoV-2 NGS services in December 2020 to provide full length viral genome sequences to researchers throughout the world working on vaccine development. 
  • The GeoMx DSP service from NanoString for protein expression analysis and morphological gene was launched by GENEWIZ in October. 
  • Indivumed GmbH launched nRavel, a new artificial intelligence discovery platform for precision medicine and oncology in July 2021. IndivuType’s deep multi-omics information and data is combined with extensive disease models, high powered automated machine learning methods, and a huge selection of latest and advanced analytical tools in this platform. 
  • StrandAdvantage500, a Next Generation Sequencing based assay that evaluates cancer relevant genetic changes using RNA and DNA taken from a patient’s tumor in one integrated workflow, was launched in April 2020 by Strand Life Sciences and Healthcare Global Enterprises

Some of the prominent players in the global bioinformatics market include:

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • QIAGEN N.V. 
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Waters Corporation
  • NeoGenomics Laboratories
  • Perkin Elmer Inc.
  • Fios Genomics
  • Source BioScience

Segments Covered in the Report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Product

  • Bioinformatics Platforms
    • Sequence Analysis Platform
    • Sequence Alignment Platform
    • Sequence Manipulation Platform
    • Structural and Functional Analysis Platform
    • Other
  • Bioinformatics Services
    • Sequencing Services
    • Database and Management Services
    • Data Analysis
    • Other
  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Biocontent

By Application

  • Genomics
  • Molecular Phylogenetics
  • Metabolomics
  • Proteomics
  • Transcriptions
  • Chemoinformatics and Drug Designing
  • Others

By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Other Sectors

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of bioinformatics market?
The global bioinformatics market size was reached at US$ 13.2 billion in 2021 and it is anticipated to rake US$ 45.6 billion by 2030.
The global bioinformatics market is expected to grow at a CAGR of 16.3% from 2022 to 2030.
The major players operating in the bioinformatics market are Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies Inc., Illumina Inc., Waters Corporation, NeoGenomics Laboratories, Perkin Elmer Inc., Fios Genomics, and Source BioScience
Growing investments in biology and information technology sectors is a primary driving factors of the bioinformatics market.
Europe region is expected to develop at the fastest rate during the forecast period.

PROCEED TO BUY

   USD 4500
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample